« Back
Home /
MGCD-265 analog

MGCD-265 analog

Item no.	TMO-T6351-1mg
Manufacturer	TargetMol
CASRN	875337-44-3
Amount	1 mg
Quantity options	100 mg 10 mM x 1 mL (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Glesatinib analog, MGCD-265
Shipping condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|c-Met/HGFR\|\|\|VEGFR
	MET
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	517, 6
Target names or alias	Glesatinib , MGCD-265
Description	MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
Pathways	Apoptosis\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6351-1mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time